Hristina Beeva

Creative Edge Nutrition, Inc. (OTCMKTS:FITX) Boosted by Forbes Magazine Article

by Hristina Beeva January 2, 2014
The end of the year looks like a harvest time for any ticker that decided to affiliate itself with the medical marijuana story. Creative Edge Nutrition, Inc. (OTCMKTS:FITX, FITX message board), a regular supplements provider for the fitness industry, made the switch in mid-November, stating it would be opening a medical marijuana facility soon. FITX0201.png

FITX is still in the highly volatile double-zero range, so it easily added more than 37% at the final day of trading for 2013, reaching $0.005. Dollar volumes were above $1.19 million, and the ticker has been trending for a while, which differentiates it from more volatile sub-penny stocks. 0PHOT0201.png

FITX has not been promoted for a while, but had an end-of-year run boosted by medical marijuana news. So FITX also benefits from the further liberalization of cannabis, this time for recreational use, starting at the beginning of 2014 in Colorado, and possibly in other states in the near future. But we have to wait and see, as in the case of other companies, how FITX translates this into sales and bottom-line results.

We have not visited FITX since October, when the ticker began the climb in earnest. On the positive side, FITX is not in active promotion. Still, the latest trend is caused by external news, and may see reversals in the near future.

The latest filings show that despite the pink sheet status and the low price, FITX may be equipped to go on with supplement and medical marijuana sales. The latest 10-K from November shows:

  • $5.68 million cash
  • $34.4 million total current assets
  • $18.8 million total current liabilities
  • $31 million gross sales
  • $3.9 million net loss

The major obstacle for FITX is to achieve profitability, though it has been closing the gap in the past quarters. Still, the extremely low stock price may move on its own laws, based on investors' sentiment and PR noise. Luckily for now, there is a lot of optimism around FITX as a potentially lucrative selection, expecting a breakout- though with some caution of potential sessions in the red.

To compare, Growlife, Inc. (OTCBB:PHOT) has been on a similar run, multiplying its price three times since the dip in late November.

We can't predict how long the run will continue for FITX, but in any case, avoid investing sums that you cannot afford to lose on a reversal of the trend.

Comments 0

Type the characters that you see in the box (5 characters).